287 related articles for article (PubMed ID: 10356396)
1. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.
Morgunova E; Tuuttila A; Bergmann U; Isupov M; Lindqvist Y; Schneider G; Tryggvason K
Science; 1999 Jun; 284(5420):1667-70. PubMed ID: 10356396
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
Stack MS; Itoh Y; Young TN; Nagase H
Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic and non-proteolytic activation of human neutrophil progelatinase B.
Sang QX; Birkedal-Hansen H; Van Wart HE
Biochim Biophys Acta; 1995 Sep; 1251(2):99-108. PubMed ID: 7669817
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
[TBL] [Abstract][Full Text] [Related]
5. Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase.
Cao J; Rehemtulla A; Pavlaki M; Kozarekar P; Chiarelli C
J Biol Chem; 2005 Mar; 280(12):10974-80. PubMed ID: 15637056
[TBL] [Abstract][Full Text] [Related]
6. Identification of the TIMP-2 binding site on the gelatinase A hemopexin C-domain by site-directed mutagenesis and the yeast two-hybrid system.
Overall CM; King AE; Bigg HF; McQuibban A; Atherstone J; Sam DK; Ong AD; Lau TT; Wallon UM; DeClerck YA; Tam E
Ann N Y Acad Sci; 1999 Jun; 878():747-53. PubMed ID: 10415826
[No Abstract] [Full Text] [Related]
7. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13).
Knäuper V; Smith B; López-Otin C; Murphy G
Eur J Biochem; 1997 Sep; 248(2):369-73. PubMed ID: 9346290
[TBL] [Abstract][Full Text] [Related]
8. An analysis of the conformational changes that accompany the activation and inhibition of gelatinase A.
Crabbe T; Kelly SM; Price NC
FEBS Lett; 1996 Feb; 380(1-2):53-7. PubMed ID: 8603746
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
Crabbe T; Zucker S; Cockett MI; Willenbrock F; Tickle S; O'Connell JP; Scothern JM; Murphy G; Docherty AJ
Biochemistry; 1994 May; 33(21):6684-90. PubMed ID: 7911325
[TBL] [Abstract][Full Text] [Related]
10. TIMP-2 is required for efficient activation of proMMP-2 in vivo.
Wang Z; Juttermann R; Soloway PD
J Biol Chem; 2000 Aug; 275(34):26411-5. PubMed ID: 10827175
[TBL] [Abstract][Full Text] [Related]
11. New leads to cancer, arthritis therapies.
Hagmann M
Science; 1999 Jun; 284(5420):1600-1. PubMed ID: 10383332
[No Abstract] [Full Text] [Related]
12. Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation.
Nagase H; Suzuki K; Itoh Y; Kan CC; Gehring MR; Huang W; Brew K
Adv Exp Med Biol; 1996; 389():23-31. PubMed ID: 8860990
[No Abstract] [Full Text] [Related]
13. Gelatinases A and B.
Murphy G; Crabbe T
Methods Enzymol; 1995; 248():470-84. PubMed ID: 7674939
[No Abstract] [Full Text] [Related]
14. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
15. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
[TBL] [Abstract][Full Text] [Related]
16. Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Boon L; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Colau D; Gordon-Alonso M; van der Bruggen P; Stöcker W; Becker-Pauly C; Witters P; Morava E; Jaeken J; Proost P; Opdenakker G
FEBS J; 2019 Mar; 286(5):930-945. PubMed ID: 30422384
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix.
Rice A; Banda MJ
Biochemistry; 1995 Jul; 34(28):9249-56. PubMed ID: 7619826
[TBL] [Abstract][Full Text] [Related]
18. The 9-kDa N-terminal propeptide domain of MT1-MMP is required for the activation of progelatinase A.
Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
Ann N Y Acad Sci; 1999 Jun; 878():710-2. PubMed ID: 10415815
[No Abstract] [Full Text] [Related]
19. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.
Fujimoto N; Ward RV; Shinya T; Iwata K; Yamashita K; Hayakawa T
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162
[TBL] [Abstract][Full Text] [Related]
20. Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin.
Sang QA; Bodden MK; Windsor LJ
J Protein Chem; 1996 Apr; 15(3):243-53. PubMed ID: 8804571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
